Skip to main content
. Author manuscript; available in PMC: 2021 Apr 29.
Published in final edited form as: Cancer Prev Res (Phila). 2020 Jun 24;13(9):783–794. doi: 10.1158/1940-6207.CAPR-19-0412

Figure 2. Magnitude of methylation differs in DNA from paired tumor, urine (trans-renal DNA -TrDNA), plasma/serum, vaginal swabs and ascites specimens.

Figure 2.

HIST1H2BB and MAGI2 methylation was measured by quantitative Methylation Specific PCR (qMSP) and compared in DNA from paired tumor, urine (TrDNA), plasma/serum, vaginal swab and ascites specimens. A) Box-plots show that qMSP levels of HIST1H2BB were significantly higher in TrDNA compared to vaginal swabs (p=0.03), and higher in serum/plasma compared to vaginal swabs (p=0.03). B) Box-plots show that qMSP levels of MAGI2 methylation were higher in TrDNA compared to serum/plasma (p=0.02), and higher in TrDNA compared to vaginal swabs (p=0.05).